The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML. This $9,746.45 award does not have a set-aside designation and is for delivery by January 24, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, provides pharmaceutical products and services to U.S. government agencies, primarily the Department of...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Pulmozyme 1 mg/mL ampul 2.5 mL. The $2,410.99 firm fixed-price contract has a completion date of March 22, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA for a wide range of pharmaceutical products and medical supplies to support the Department of Defense worldwide. This...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $77,882.80 to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a completion date of August 18, 2022. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,159,118 units of the pharmaceutical product Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has a ceiling value of $15,650.51 and an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order contract...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $3,264.07 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,558,409 units of the prescription medication Pulmozyme 1 mg/ml ampul 2.5ml. The contract has an ultimate completion date of May 10, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, leverages its parent company's extensive supply chain to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a potential value of $5,130.50 and a completion date of March 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance...
This federal contract award is a delivery order valued at $2,540.23, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a completion date of February 9, 2024. The contract type is firm fixed price. Amerisourcebergen Drug Corp is an established prime contractor providing a wide range of pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency Troop Support Medical awarded a $11,864.81 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Pulmozyme 1 mg/mL ampules. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,640.92, is a delivery order for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product. The contract has a firm fixed price and an ultimate completion date of March 26, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialty pharmaceutical product, with a potential value of $7,232.97 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...